Shuchi Nahar's Weekend Blog!

Healthcare Global Enterprise Ltd. -  India's Leading Oncology Focused Network Background Established in 1989, Healthcare Global Enterprises Limited (HCG), is present primarily in the oncology field with the largest cancer care network (with 22 cancer care centers as of December 2021) and three multi-specialty hospitals. It is promoted by Dr. B.S. Ajai Kumar, practicing radiation and medical oncologist with over 30 years of experience. Originally established with a single cancer care center, the Bangalore Institute of Oncology (BIO), at Bangalore by Dr. B.S. Ajai Kumar and four other oncologists, the company has rapidly expanded its presence to Ahmedabad, Chennai, Nasik, Ranchi, Rajkot, Cuttack, Hubli, Mumbai, Nagpur, Vizag, and Vijayawada, among others. The company is now present across the oncology value chain, offering services from prevention, screening, diagnosis, and treatment to rehabilitation, supportive care, and palliative care. Pursuant to the Investment Agreement enter

CAPEX Acceleration in Indian Chemical Companies -  USD 300 bn  domestic market by 2025 Twitter Handle: @shuchi_nahar India’s chemical industry was estimated to be worth USD 178 billion in FY 2019-20 and has a significant potential to reach USD 300 billion by FY 2024-25. In terms of demand, the industry has grown at approximately 1.3 times the country’s average GDP growth in the last five years and shows a strong linkage with its GDP. Indian specialty chemical sector has grown at 12%+ in the last five years and is well poised to expand its global market share to 7-8% from 4% in the coming years. The structural drivers are in place like global best practice manufacturing standard and R&D capability along with government impetus of make in India policy with pro-growth policies will act as a further catalyst for growth. Further, a global MNC looking at China Plus one strategy will help Indian incumbents to gain market share. In the short to medium term, supply disruptions emerging

Ethanol - Global Production, Capacity, Impact, and Ethanol Blending Trend Twitter Handle: @shuchi_nahar In continuation with the previous Ethanol blog here is an extended version with more new Insights! With a view to give a boost to the agriculture sector and to reduce environmental pollution, the government of India had launched pilot projects in 2001 wherein, 5% ethanol blended petrol was supplied to retail outlets. Apart from field trials, R&D studies were also simultaneously conducted. The success of these field trials and studies paved the way for EBP in India. The Government of India vide its Resolution dated 3rd September 2002 decided to launch Ethanol Blended Petrol (EBP) Program in January 2003 for sale of 5% ethanol blended petrol in nine States and four UTs.   The global production of fuel ethanol touched 110 billion liters in 2019 showing an average growth of 4% a year per year during the last decade. The United States of America (USA) and Brazil contribute for 92

Laurus Labs - Result Update Q4FY21 & Full Year FY21 Twitter Handle: @shuchi_nahar Laurus Labs Limited on 30th April 2021 announced its Q4FY21 and full-year results.  Laurus Lab performed extremely well consecutive in the 4th Quarter of FY21. The company did a robust growth in all three segments. Having a healthy order book for FY 22. Consolidated revenue for the quarter increased by 70% driven by growth in all the divisions. The company has been able to sustain its EBITDA margins, and profitability has also improved to Rs. 297 Crs. for the quarter. Generic API division showcased a robust growth of 61% YoY. Anti Viral segment recorded a robust growth of 70% YoY. Revenue Showcased a healthy growth of 102% YoY. The growth was led by higher LMIC Market volumes and increased volumes from North America and EU Commenced marketing of in-licensed products in the USA to leverage front-end capabilities. Custom Synthesis division recorded a strong growth of 35% YoY. Capacity Expansion – To

Syngene Q4FY21 and Full Year FY21 - Result Update  Twitter Handle: @shuchi_nahar Syngene International Limited on 28 th April 2021 announced its Q4FY21 and full-year results. The Company reported quarterly revenue from operations of Rs. 659 Cr and Rs. 2,184 Cr for the full year. Underlying revenue from operations (excluding export incentives) for the quarter grew 13% compared with the same period last year and by 12% for the full year. Profit after tax (before exceptional gain) for the quarter increased by 15% year-on-year to Rs. 138 Cr, and by 4% to Rs. 382 Cr for the full year. Revenue Growth over the Years 1. Growth driven by an increase in sales from existing clients and acquisition of new clients  2. Engage, expand and extend the strategy to extend client relationship over a longer period of time  3. Growth in the total number of clients  4. Increase in average revenue from largest clients  5. Increase in number of services offered to clients The highlight of the quarter was the

Deepak Nitrite all set to capture opportunities across the chemicals and speciality chemicals landscape  Twitter Handle: @shuchi_nahar About  the Company From a bulk commodity products manufacturer, Deepak Nitrite Ltd. (DNL) has evolved into a specialty chemical company operating in three key division i.e Basic Chemicals, Fine and Specialty Chemicals and Performance Products with facilities located at Dahej, Nandesari, Roha, Taloja and Hyderabad. DNL has a number of credits to its name for manufacturing of chemicals holds a leading position in products such as Sodium Nitrite, Nitro toluene - the only company in India to have fully integrated OBA setup. The company dictates 80% domestic market share in sodium nitrite and 50% market share in nitro toluene. Also, nitro toluene acts as a key raw material for the Performance Chemicals segment. The end-user applications of DNL’s products vary from agrochemicals, dyes, and pigments to pharmaceuticals, rubber chemicals, refinery, textile,